High frequency of allele-specific rown-regulation of HLA class I expression in lung cancer cell lines

Akio Hiraki, Nobuharu Fujii, Tomoyuki Murakami, Katsuyuki Kiura, Keisuke Aoe, Hiromichi Yamane, Kozo Masuda, Tadashi Maeda, Kazuro Sugi, Zbigniew Darzynkiewicz, Mitsune Tanimoto, Mine Harada

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Loss or down-regulation of HLA expression has been demonstrated in various types of solid tumors and is considered to be one of the mechanisms of tumor immunoescape. The effectiveness of immunotherapy using tumor-specific antigens (TSA) largely depends on the expression of the appropriate HLA class I alleles on the tumor cells. We analyzed the allele-specific HLA class I surface expression of six lung cancer cell lines using a broad panel of allele-specific monoclonal antibodies, as well as the effect of IFN-γ on HLA expression. Flow cytometric analysis displayed a wide range, from minimal to a high degree of expression of monomorphic HLA class I among the studied cell lines. Allele-specific loss or down-regulation of HLA also was observed in 5 out of 6 cell lines. Our results suggest that lung cancer patients considered for specific immunotherapy should be examined with respect to the expression of specific HLA class I allele binding the TSA.

Original languageEnglish
Pages (from-to)1525-1528
Number of pages4
JournalAnticancer Research
Volume24
Issue number3 A
Publication statusPublished - May 2004

Fingerprint

Gene Frequency
Lung Neoplasms
Alleles
Cell Line
Neoplasm Antigens
Immunotherapy
Down-Regulation
Neoplasms
Monoclonal Antibodies

Keywords

  • HLA
  • Immunoescape
  • Immunotherapy
  • Lung cancer cells

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

High frequency of allele-specific rown-regulation of HLA class I expression in lung cancer cell lines. / Hiraki, Akio; Fujii, Nobuharu; Murakami, Tomoyuki; Kiura, Katsuyuki; Aoe, Keisuke; Yamane, Hiromichi; Masuda, Kozo; Maeda, Tadashi; Sugi, Kazuro; Darzynkiewicz, Zbigniew; Tanimoto, Mitsune; Harada, Mine.

In: Anticancer Research, Vol. 24, No. 3 A, 05.2004, p. 1525-1528.

Research output: Contribution to journalArticle

Hiraki, A, Fujii, N, Murakami, T, Kiura, K, Aoe, K, Yamane, H, Masuda, K, Maeda, T, Sugi, K, Darzynkiewicz, Z, Tanimoto, M & Harada, M 2004, 'High frequency of allele-specific rown-regulation of HLA class I expression in lung cancer cell lines', Anticancer Research, vol. 24, no. 3 A, pp. 1525-1528.
Hiraki, Akio ; Fujii, Nobuharu ; Murakami, Tomoyuki ; Kiura, Katsuyuki ; Aoe, Keisuke ; Yamane, Hiromichi ; Masuda, Kozo ; Maeda, Tadashi ; Sugi, Kazuro ; Darzynkiewicz, Zbigniew ; Tanimoto, Mitsune ; Harada, Mine. / High frequency of allele-specific rown-regulation of HLA class I expression in lung cancer cell lines. In: Anticancer Research. 2004 ; Vol. 24, No. 3 A. pp. 1525-1528.
@article{b2c1a2ccd2fa45f4b1bbed9ebe0376d3,
title = "High frequency of allele-specific rown-regulation of HLA class I expression in lung cancer cell lines",
abstract = "Loss or down-regulation of HLA expression has been demonstrated in various types of solid tumors and is considered to be one of the mechanisms of tumor immunoescape. The effectiveness of immunotherapy using tumor-specific antigens (TSA) largely depends on the expression of the appropriate HLA class I alleles on the tumor cells. We analyzed the allele-specific HLA class I surface expression of six lung cancer cell lines using a broad panel of allele-specific monoclonal antibodies, as well as the effect of IFN-γ on HLA expression. Flow cytometric analysis displayed a wide range, from minimal to a high degree of expression of monomorphic HLA class I among the studied cell lines. Allele-specific loss or down-regulation of HLA also was observed in 5 out of 6 cell lines. Our results suggest that lung cancer patients considered for specific immunotherapy should be examined with respect to the expression of specific HLA class I allele binding the TSA.",
keywords = "HLA, Immunoescape, Immunotherapy, Lung cancer cells",
author = "Akio Hiraki and Nobuharu Fujii and Tomoyuki Murakami and Katsuyuki Kiura and Keisuke Aoe and Hiromichi Yamane and Kozo Masuda and Tadashi Maeda and Kazuro Sugi and Zbigniew Darzynkiewicz and Mitsune Tanimoto and Mine Harada",
year = "2004",
month = "5",
language = "English",
volume = "24",
pages = "1525--1528",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3 A",

}

TY - JOUR

T1 - High frequency of allele-specific rown-regulation of HLA class I expression in lung cancer cell lines

AU - Hiraki, Akio

AU - Fujii, Nobuharu

AU - Murakami, Tomoyuki

AU - Kiura, Katsuyuki

AU - Aoe, Keisuke

AU - Yamane, Hiromichi

AU - Masuda, Kozo

AU - Maeda, Tadashi

AU - Sugi, Kazuro

AU - Darzynkiewicz, Zbigniew

AU - Tanimoto, Mitsune

AU - Harada, Mine

PY - 2004/5

Y1 - 2004/5

N2 - Loss or down-regulation of HLA expression has been demonstrated in various types of solid tumors and is considered to be one of the mechanisms of tumor immunoescape. The effectiveness of immunotherapy using tumor-specific antigens (TSA) largely depends on the expression of the appropriate HLA class I alleles on the tumor cells. We analyzed the allele-specific HLA class I surface expression of six lung cancer cell lines using a broad panel of allele-specific monoclonal antibodies, as well as the effect of IFN-γ on HLA expression. Flow cytometric analysis displayed a wide range, from minimal to a high degree of expression of monomorphic HLA class I among the studied cell lines. Allele-specific loss or down-regulation of HLA also was observed in 5 out of 6 cell lines. Our results suggest that lung cancer patients considered for specific immunotherapy should be examined with respect to the expression of specific HLA class I allele binding the TSA.

AB - Loss or down-regulation of HLA expression has been demonstrated in various types of solid tumors and is considered to be one of the mechanisms of tumor immunoescape. The effectiveness of immunotherapy using tumor-specific antigens (TSA) largely depends on the expression of the appropriate HLA class I alleles on the tumor cells. We analyzed the allele-specific HLA class I surface expression of six lung cancer cell lines using a broad panel of allele-specific monoclonal antibodies, as well as the effect of IFN-γ on HLA expression. Flow cytometric analysis displayed a wide range, from minimal to a high degree of expression of monomorphic HLA class I among the studied cell lines. Allele-specific loss or down-regulation of HLA also was observed in 5 out of 6 cell lines. Our results suggest that lung cancer patients considered for specific immunotherapy should be examined with respect to the expression of specific HLA class I allele binding the TSA.

KW - HLA

KW - Immunoescape

KW - Immunotherapy

KW - Lung cancer cells

UR - http://www.scopus.com/inward/record.url?scp=3242694336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242694336&partnerID=8YFLogxK

M3 - Article

C2 - 15274319

AN - SCOPUS:3242694336

VL - 24

SP - 1525

EP - 1528

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3 A

ER -